Ux023t-Cl201
Research payments
$1,519,487
Through program year 2022, $1,519,487 in research payments was reported against Ux023t-Cl201, across 13 payments, paid by Ultragenyx Pharmaceutical Inc..
- Paid by
- Ultragenyx Pharmaceutical Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $53,477 | 1 |
| 2020 | Research | $616,891 | 7 |
| 2019 | Research | $849,120 | 5 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Paul Miller Golden, CO Named on 2 payments
- Munro Peacock Indianapolis, IN Named on 2 payments
- Rajiv Kumar Rochester, MN Named on 2 payments
- Suzanne Jan De Beur Baltimore, MD Named on 2 payments
- Thomas Weber Durham, NC Named on 2 payments
- Thomas Carpenter New Haven, CT Named on 2 payments
- Dale Hamilton Houston, TX Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.